These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 37242649)

  • 1. Responsive Microneedles as a New Platform for Precision Immunotherapy.
    Liu X; Song H; Sun T; Wang H
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress of microneedles in transdermal immunotherapy: A review.
    Ai X; Yang J; Liu Z; Guo T; Feng N
    Int J Pharm; 2024 Jul; 662():124481. PubMed ID: 39025342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimuli-Responsive Microneedles as a Transdermal Drug Delivery System: A Demand-Supply Strategy.
    Gowda BHJ; Ahmed MG; Sahebkar A; Riadi Y; Shukla R; Kesharwani P
    Biomacromolecules; 2022 Apr; 23(4):1519-1544. PubMed ID: 35274937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microneedles: A New Generation Vaccine Delivery System.
    Menon I; Bagwe P; Gomes KB; Bajaj L; Gala R; Uddin MN; D'Souza MJ; Zughaier SM
    Micromachines (Basel); 2021 Apr; 12(4):. PubMed ID: 33919925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microneedles: A smart approach and increasing potential for transdermal drug delivery system.
    Waghule T; Singhvi G; Dubey SK; Pandey MM; Gupta G; Singh M; Dua K
    Biomed Pharmacother; 2019 Jan; 109():1249-1258. PubMed ID: 30551375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smart Responsive Microneedles for Controlled Drug Delivery.
    Qi Z; Yan Z; Tan G; Kundu SC; Lu S
    Molecules; 2023 Nov; 28(21):. PubMed ID: 37959830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a core-shell microneedle system to achieve targeted co-delivery of checkpoint inhibitors for melanoma immunotherapy.
    Yang P; Lu C; Qin W; Chen M; Quan G; Liu H; Wang L; Bai X; Pan X; Wu C
    Acta Biomater; 2020 Mar; 104():147-157. PubMed ID: 31904558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microneedle-based vaccines.
    Prausnitz MR; Mikszta JA; Cormier M; Andrianov AK
    Curr Top Microbiol Immunol; 2009; 333():369-93. PubMed ID: 19768415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Progress in Microneedles-Mediated Diagnosis, Therapy, and Theranostic Systems.
    Yang J; Yang J; Gong X; Zheng Y; Yi S; Cheng Y; Li Y; Liu B; Xie X; Yi C; Jiang L
    Adv Healthc Mater; 2022 May; 11(10):e2102547. PubMed ID: 35034429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in microneedle-based transdermal delivery for drugs and peptides.
    Aich K; Singh T; Dang S
    Drug Deliv Transl Res; 2022 Jul; 12(7):1556-1568. PubMed ID: 34564827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward Biofunctional Microneedles for Stimulus Responsive Drug Delivery.
    Cahill EM; O'Cearbhaill ED
    Bioconjug Chem; 2015 Jul; 26(7):1289-96. PubMed ID: 26020359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microneedle-Mediated Transdermal Delivery of Biopharmaceuticals.
    Nguyen HX; Nguyen CN
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical Delivery of ROS-Responsive Methotrexate Prodrug Nanoassemblies by a Dissolvable Microneedle Patch for Psoriasis Therapy.
    Zhou Y; Yang L; Lyu Y; Wu D; Zhu Y; Li J; Jiang D; Xin X; Yin L
    Int J Nanomedicine; 2023; 18():899-915. PubMed ID: 36824414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microneedles-Based Transdermal Drug Delivery Systems: A Review.
    Hao Y; Li W; Zhou X; Yang F; Qian Z
    J Biomed Nanotechnol; 2017 Dec; 13(12):1581-1597. PubMed ID: 29490749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microneedle-Facilitated Intradermal Proretinal Nanoparticle Delivery.
    Limcharoen B; Toprangkobsin P; Kröger M; Darvin ME; Sansureerungsikul T; Rujwaree T; Wanichwecharungruang S; Banlunara W; Lademann J; Patzelt A
    Nanomaterials (Basel); 2020 Feb; 10(2):. PubMed ID: 32093242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal Insulin Delivery and Microneedles-based Minimally Invasive Delivery Systems.
    Hong Y; Yu H; Wang L; Chen X; Huang Y; Yang J; Ren S
    Curr Pharm Des; 2022; 28(39):3175-3193. PubMed ID: 35676840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microneedles as an alternative technology for transdermal drug delivery systems: a patent review.
    Queiroz MLB; Shanmugam S; Santos LNS; Campos CA; Santos AM; Batista MS; Araújo AAS; Serafini MR
    Expert Opin Ther Pat; 2020 Jun; 30(6):433-452. PubMed ID: 32164470
    [No Abstract]   [Full Text] [Related]  

  • 18. Current trends in polymer microneedle for transdermal drug delivery.
    Ahmed Saeed Al-Japairai K; Mahmood S; Hamed Almurisi S; Reddy Venugopal J; Rebhi Hilles A; Azmana M; Raman S
    Int J Pharm; 2020 Sep; 587():119673. PubMed ID: 32739388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microneedles: an emerging transdermal drug delivery system.
    Bariya SH; Gohel MC; Mehta TA; Sharma OP
    J Pharm Pharmacol; 2012 Jan; 64(1):11-29. PubMed ID: 22150668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery.
    Caudill CL; Perry JL; Tian S; Luft JC; DeSimone JM
    J Control Release; 2018 Aug; 284():122-132. PubMed ID: 29894710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.